Latest Laboratory Services News

Microba Life Sciences reports robust year-on-year growth in microbiome testing volumes and revenue, advancing towards regional break-even in Australia and the UK while progressing its therapeutic pipeline.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

Marmota Limited is progressing its scoping study for the Gawler Gold Project, aiming to establish a heap leach facility processing 1 million tonnes annually over seven years. Completion is targeted by March 2026, with key technical workstreams underway.

ALS Limited has reported a robust first half for FY26, with revenue climbing 13.3% to $1.7 billion and underlying NPAT rising 17.2%, driven by strong organic growth across all business streams and strategic investments in digital innovation.

BPH Global has initiated new seaweed sampling in the Johor Strait to analyze precious metals and rare earth elements, aiming to enhance its mineral recovery and environmental remediation efforts.

Savannah Goldfields is on track to resume gold production at its Georgetown Gold Project by the end of October, with key maintenance and environmental approvals completed.

Indiana Resources Limited has explained recent unusual trading activity by revealing ongoing assay result delays and heightened investor engagement led by its new Managing Director.

BPH Global has secured a 12-month Master Services Agreement with Singapore’s Marchwood Laboratory Services to enhance its research on extracting rare earth elements from seaweed, focusing on four critical metals vital to clean energy and technology.

Sonic Healthcare delivered solid FY2025 results with 8% revenue growth and a 7% rise in net profit, setting the stage for an anticipated 19% earnings per share increase in FY2026.

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.

Telix Pharmaceuticals reported a robust 63% revenue increase in H1 2025, driven by commercial growth and strategic investments, while advancing key clinical trials and maintaining full-year guidance.

Victory Metals Ltd has announced a substantial upgrade to its North Stanmore Heavy Rare Earth Element Project, increasing the mineral resource by nearly 30% and revealing some of the highest heavy rare earth element ratios recorded in Australia.